Megna Michael R sold KNSA

September 3, 2025 · Form 4 insider transaction

Megna Michael R sold 11,000 shares of Kiniksa Pharmaceuticals International, plc at $34.84 per share, a transaction worth $383.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
11,000
Price
$34.84
Total value
$383.2K
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2025
Filing dateSeptember 3, 2025
Shares owned after38,011
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $34.80 and $35.005. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

View the original Form 4 on SEC EDGAR
Megna Michael R sold KNSA: September 3, 2025 | Insider Trading Screener